Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients

Clin Exp Allergy. 2025 Jan;55(1):97-99. doi: 10.1111/cea.14585. Epub 2024 Oct 24.
No abstract available